Evidence map›Paper›PMID 27743938›Full record

ArticleOral oncology2016

Squamous cell carcinoma associated with chronic graft versus host disease-like/lichen planus-like lesion of the oral cavity in a patient managed for metastatic melanoma with a PD-1 inhibitor pembrolizumab.

Adepitan A Owosho, Joseph Randazzo, Evan B Rosen, Cherry L Estilo, Joseph M Huryn, Ping Chi, SaeHee K Yom

Abstract readCase ReportsLetter
In one paragraph

Article in Oral oncology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

  1. MASCC/ISOO Clinical Practice Statement: management of oral complications of immunotherapy.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025
    Guideline
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Adepitan A OwoshoDental Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, United States.
Joseph RandazzoDental Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, United States.
Evan B RosenDental Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, United States.
Cherry L EstiloDental Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, United States.
Joseph M HurynDental Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, United States.
Ping ChiDepartment of Medicine, Memorial Sloan Kettering Cancer Center, New York, United States; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, United States.
SaeHee K YomDental Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10065, United States. Electronic address: kims2@mskcc.org.
Memorial Sloan Kettering Cancer Center · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antibodies, Monoclonal, HumanizedAntineoplastic Agents, ImmunologicalCarcinoma, Squamous CellChronic DiseaseGraft vs Host DiseaseHumansLichen PlanusMaleMelanomaMiddle AgedNeoplasm MetastasisProgrammed Cell Death 1 ReceptorAntibodies, Monoclonal, HumanizedAntineoplastic Agents, ImmunologicalPDCD1 protein, humanpembrolizumabProgrammed Cell Death 1 Receptor

Identifiers

PMID27743938
PMCPMC5599103
OpenAlexW2530674660

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.